We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current ORGS market cap is 6.72M. The company's latest EPS is USD -10.7097 and P/E is -0.20.
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 33.48M | 7.76M | 37.78M | 36.03M | 530k |
Operating Income | -24.6M | -95.68M | -14.52M | -8.6M | -52.94M |
Net Income | -24.12M | -94.6M | -18.05M | -14.89M | -55.36M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 92.5M | 77.68M | 59.84M | 90.93M | 14.55M |
Total Liabilities | 55.46M | 24.96M | 21.21M | 31.65M | 35.54M |
Total Equity | 6.08M | 52.73M | 38.63M | 29.07M | -20.98M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -13.22M | -78.05M | -26.87M | -24.92M | -14.84M |
Investing | -13.78M | 105.61M | -12.38M | -14.13M | -3.71M |
Financing | 24.1M | 5.88M | -106k | 39.58M | 13.62M |
Market Cap | 6.72M |
Price to Earnings Ratio | -0.20 |
Price to Sales Ratio | 20.59 |
Price to Cash Ratio | 13.03 |
Price to Book Ratio | -0.52 |
Dividend Yield | - |
Shares Outstanding | 5.17M |
Average Volume (1 week) | 12.88k |
Average Volume (1 Month) | 9.01k |
52 Week Change | -85.96% |
52 Week High | 9.26 |
52 Week Low | 0.87 |
Spread (Intraday) | 0.62 (41.61%) |
Company Name | Orgenesis Inc (QX) |
Address |
701 s carson st carson city, nevada 89701 |
Website | https://orgenesis.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions